Full Paper
2
1
Ar), 129.2 (q, J(C,F)=31 Hz; m-Ar), 124.9 (q, J(C,F)=273 Hz; CF3),
117.8 ppm (p-Ar). The synthesis and characterisation of ligands b–
d, compounds 1a·Cl–1d·Cl, [1a]BArF–[1d]BArF, [1a·CO]BArF–
[1d·CO]BArF and [1a·L]BArF are reported in the Supporting
Information.
Synthesis and characterisation
Compound [2a]BArF: A solution of compound [1a]BArF (0.1 g,
0.065 mmol) in CH2Cl2 (5 mL) at 08C was treated with H2 (0.5 bar)
and the mixture was stirred for 6 h. 1H NMR analysis of the reaction
mixture revealed the formation of complex 2a+ and its isomer
1a+ in approximately a 1:1 ratio. [2a]BArF was separated by frac-
tional crystallisation from Et2O/hexane mixtures at ꢀ238C as
orange crystals. 1H NMR (500 MHz, CD2Cl2, 258C): d=7.72 (m,
3
3J(H,H)ꢁ7.5 Hz, 1H; CHXyl), 7.59 (t, J(H,H)ꢁ7.5 Hz, 1H; CHPyridine(Pyr)),
7.48 (t, 3J(H,H)=8.2 Hz, 1H; CHDiisopropylphenyl(Dipp)), 7.45 (t, 3J(H,H)
ꢁ7.5 Hz, 1H; CHXyl), 7.37 (d, 3J(H,H)ꢁ7.5 Hz, 1H; CHXyl), 7.30 (d,
3J(H,H)=8.2 Hz, 1H; CHDipp), 7.01 (d, 3J(H,H)=8.2 Hz, 1H; CHDipp),
6.11 (d, 3J(H,H)ꢁ7.5 Hz, 1H; CHPyr), 6.04 (d, 3J(H,H)ꢁ7.5 Hz, 1H;
2
CHPyr), 5.94 (s, 1H; NH), 3.68 (d, J(H,H)=4.5 Hz, 1H; IrꢀCHH), 3.19
(septet, 3J(H,H)ꢁ7.0 Hz, 1H; CHiPr), 2.78 (septet, 3J(H,H)ꢁ7.0 Hz,
1H; CHiPr), 2.48 (s, 3H; 1ꢆMexyl), 2.07 (d, 2J(H,H)=4.5 Hz, 1H; Irꢀ
CHH), 1.61 (s, 15H; 5ꢆMeCp*), 1.30 (d, 3J(H,H)ꢁ7.0 Hz, 3H; MeiPr),
1.28 (d, 3J(H,H)ꢁ7.0 Hz, 3H; MeiPr), 1.26 (d, 3J(H,H)ꢁ7.0 Hz, 3H;
MeiPr), 1.01 ppm (d, J(H,H)ꢁ7.0 Hz, 3H; MeiPr); 13C NMR (125 MHz,
3
CD2Cl2, 258C): d=157.1 (Cq-Pyr), 154.2 (Cq-Pyr), 148.0 (Cq-Dipp), 147.7
Scheme 9. Proposed mechanism for the H2-catalysed isomerisation between
species 1a+ and 2a+.
(Cq-Dipp), 146.2 (Cq-Dipp), 141.4 (CHPyr), 137.7 (Cq-Xyl), 134.0, 130.0,
129.6, 129.4, 125.3, 125.1 (CHXyl, CHDipp), 117.8 (CHPyr), 107.5 (CHPyr),
1
100.4 (IrꢀCH2-Cq), 94.1 (IrꢀCq-xyl), 90.2 (Cq-Cp*), 34.9 (d, J(C,H)average
=
ent forms (complexes 1a+–1d+ and 2a+–2d+). We have
found that H2 catalyses a prototropic rearrangement, which in-
terchanges a hydrogen atom between one of the 2,6-benzylic
positions and the amido site of the aminopyridinate ligands
under homogeneous conditions with high efficiency. The pro-
cess implies reversible formation and cleavage of HꢀH, CꢀH
and NꢀH bonds.
155 Hz; IrꢀCH2), 29.4 (CHiPr), 28.6 (CHiPr), 25.6 (MeiPr), 23.7 (MeiPr),
23.6 (MeiPr), 23.1 (MeiPr), 20.5 (Mexyl), 8.9 ppm (MeCp*); IR (Nujol): n˜ =
3420 cmꢀ1 (br; NH); elemental analysis calcd (%) for C67H56BF24IrN2:
C 52.0, H 3.7, N 1.8; found: C 52.0, H 3.7, N 1.8.
Compounds [2b]BArF–[2d]BArF: See the Supporting Information
for synthetic details and characterisation data.
Compound 1a·H:
Method a: Tetramethylpiperidine (5 equiv) was added to an equilib-
rium mixture of 1a+ and 2a+ in CD2Cl2 and the resulting mixture
was treated with H2 (1 atm). The reaction was monitored by
1H NMR spectroscopy until 2a+ had reacted to form 1a·H.
Experimental Section
General procedures
Method b: To a solution of 1a·Cl (0.05 g, 0.072 mmol) in THF
(5 mL), NaBH4 (ꢁ10 equiv) and methanol (3 mL) were added. The
reaction mixture was stirred at RT for 14 h and the colour of the
solution changed from orange to yellow. Distilled water (3 mL) was
added and the product was extracted with toluene. The organic
phase was dried over MgSO4 and the solvent was evaporated
Microanalyses were performed by the Microanalytical Service of
the Instituto de Investigaciones Quꢁmicas (Seville, Spain). Infrared
spectra were obtained with a Bruker Vector 22 spectrometer. Mass
spectra were obtained at the Mass Spectroscopy Service of the
University of Seville. NMR spectra were recorded with a Bruker
DRX-500, DRX-400 or DPX-300 spectrometer. Spectra were refer-
enced to external SiMe4 (d=0 ppm) by using the residual protic
solvent peaks as internal standards (1H NMR experiments) or the
characteristic resonances of the solvent nuclei (13C NMR experi-
ments). Spectral assignments were made by routine one- and two-
dimensional NMR experiments if appropriate. All manipulations
were performed under dry, oxygen-free N2, by using conventional
Schlenk techniques. Crystal structures were determined with
1
under vacuum. Analysis by H NMR spectroscopy revealed quanti-
tative conversion into 1a·H. Note: 1a·H converts into 1a·Cl in the
presence of chlorinated solvents. An analytically pure sample of
1a·H could not be obtained due to its slow decomposition in solu-
1
tion when crystallising. H NMR (300 MHz, C6D6, 258C): d=7.24 (m,
3
3H; 3ꢆCHDipp), 7.05 (m, 1H; CHXyl), 6.94 (t, J(H,H)ꢁ7.5 Hz, 2H; 2ꢆ
CHXyl), 6.73 (t, 3J(H,H)ꢁ7.5 Hz, 1H; CHPyr), 5.70 (d, 3J(H,H)ꢁ7.5 Hz,
1H; CHPyr), 5.28 (d, 3J(H,H)ꢁ7.5 Hz, 1H; CHPyr), 3.97 (septet,
3
a
Bruker–Nonius, X8Kappa diffractometer. Metal complex
3J(H,H)=7.0 Hz, 1H; CHiPr), 3.64 (septet, J(H,H)=7.0 Hz, 1H; CHiPr),
[48]
[49]
[IrCl2Cp*]2 and NaBArF were prepared as previously described.
The lithium salts of the Ap ligands were prepared according to
2.46 (s, 3H; MeXyl), 2.20 (s, 3H; MeXyl), 1.41 (s, 15H; 5ꢆMeCp*), 1.38
(d, 3J(H,H)ꢁ7.0 Hz, 6H; 2ꢆMeiPr), 1.27 (d, 3J(H,H)ꢁ7.0 Hz, 3H;
publisheꢀd procedures.[14a] The H and 13C{1H} NMR spectral data for
MeiPr), 1.16 (d, J(H,H)ꢁ7.0 Hz, 3H; MeiPr), ꢀ7.39 ppm (s, 1H; IrꢀH);
1
3
the BArF anion in CD2Cl2 are identical for all complexes and there-
13C NMR (75 MHz, C6D6, 258C): d=170.7 (Cq-Pyr), 157.2 (Cq-Pyr), 146.7
(Cq-Dipp), 145.8 (Cq-Dipp), 139.9 (Cq-Xyl), 138.4 (Cq-Xyl), 137.6 (Cq-Dipp),
136.5 (Cq-Xyl), 134.1 (CHPyr), 104.8 (CHPyr), 104.0 (CHPyr), 128.2 (CHXyl),
127.9 (CHXyl), 126.8 (CHXyl), 124.9 (CHDipp), 123.8 (CHDipp), 122.9
1
fore are not repeated for each individual case below. H NMR (500
MHz, CD2Cl2): d=7.75 (s, 8H; o-Ar), 7.58 ppm (s, 4H; p-Ar); 13C NMR
(125 MHz, CD2Cl2): d=162.1 (q, 1J(C,B)=37 Hz; ipso-Ar), 135.3 (o-
Chem. Eur. J. 2014, 20, 1 – 13
9
ꢄ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ